ADP-0000-001-SCR
Phase N/A
OPEN TO ACCRUAL
A Screening Protocol to Determine Tumor Antigen Expression and HLA Sub-Type for Eligibility Determination for Clinical Trials Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs in Subjects with Solid or Hematological Malignancies
GSK-3377794-LTFU
Phase N/A
OPEN TO ACCRUAL
Long-Term Follow-Up (LTFU) of Participants Treated with GSK Adoptive Cell Therapies